|
R
0
|
Influenza A
|
Influenza B
|
Prevented
|
|---|
|
No vaccination
|
TIV or QIV
|
No vaccination
|
TIV
|
QIV
|
QIV-TIV
|
%
|
|---|
|
1.2
|
5880
|
1954
|
3054
|
1400
|
1075
|
325
|
9.5
|
|
(5823–5936)
|
(1923–1985)
|
(3018–3089)
|
(1379–1422)
|
(1056–1095)
|
(306–344)
|
(8.9-10.1)
|
|
1.3
|
7221
|
3061
|
3754
|
1999
|
1626
|
373
|
7.3
|
|
(7151–7290)
|
(3018–3104)
|
(3709–3798)
|
(1970–2028)
|
(1599–1652)
|
(350–396)
|
(6.8-7.7)
|
|
1.4
|
8359
|
4106
|
4363
|
2541
|
2167
|
374
|
5.5
|
|
(8276–8442)
|
(4055–4158)
|
(4311–4415)
|
(2506–2577)
|
(2133–2201)
|
(350–398)
|
(5.2-5.9)
|
|
1.5
|
9302
|
5009
|
4889
|
3063
|
2677
|
386
|
4.8
|
|
(9209–9395)
|
(4946–5071)
|
(4830–4947)
|
(3021–3105)
|
(2638–2717)
|
(360–411)
|
(4.4-5.1)
|
|
1.575
|
9820
|
5597
|
5229
|
3346
|
2951
|
395
|
4.3
|
|
(9750–9891)
|
(5550–5643)
|
(5183–5275)
|
(3313–3379)
|
(2920–2982)
|
(376–414)
|
(4.1-4.5)
|
|
1.6
|
10154
|
5787
|
5345
|
3482
|
3086
|
396
|
4.2
|
|
(10051–10256)
|
(5716–5858)
|
(5280–5410)
|
(3435–3529)
|
(3041–3132)
|
(370–422)
|
(3.9-4.5)
|
|
1.7
|
10893
|
6510
|
5736
|
3880
|
3469
|
411
|
3.9
|
|
(10784–11002)
|
(6433–6587)
|
(5664–5809)
|
(3826–3934)
|
(3419–3518)
|
(385–437)
|
(3.7-4.2)
|
|
1.8
|
11494
|
7116
|
6060
|
4218
|
3820
|
398
|
3.5
|
|
(11374–11614)
|
(7032–7200)
|
(5982–6138)
|
(4160–4277)
|
(3765–3875)
|
(372–424)
|
(3.3-3.7)
|
|
1.9
|
12063
|
7669
|
6383
|
4523
|
4139
|
383
|
3.1
|
|
(11935–12190)
|
(7578–7760)
|
(6301–6466)
|
(4461–4584)
|
(4081–4198)
|
(357–409)
|
(2.9-3.3)
|
|
2.0
|
12354
|
8183
|
6640
|
4790
|
4404
|
385
|
3.0
|
|
(12227–12480)
|
(8087–8279)
|
(6550–6731)
|
(4724–4855)
|
(4342–4467)
|
(359–411)
|
(2.8-3.2)
|
- Average annual results (with 95% confidence intervals) obtained for the 20 year evaluation period (calculated from 1,000 simulations for each combination of R
0
and vaccination strategy in a simulated population of about 80,000 individuals (2,000 simulations each for the baseline value of R
0
= 1.575; boldface line). The last column shows what percentage of all influenza A and B infections which occur under TIV vaccination can additionally be prevented by QIV.
